North America Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

September 2020 | 118 pages | ID: N5DDA43D51B0EN
GMD Research

Abstracts

North America PoC molecular diagnostics market is expected to grow by 12.7% annually in the forecast period and reach $2,320.5 million by 2030 driven by increase in adoption of personalized medicine and surge in usage of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.

Highlighted with 27 tables and 49 figures, this 118-page report “North America Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Kits & Assays
• Analyzers & Instruments
• Software & Services

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Polymerase Chain Reaction (PCR)

• Real-Time PCR (rt-PCR)
• Digital PCR (d-PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Genetic Sequencing-based Technology
Microarray-based Technology
Other Technologies

Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Infectious Disease

• Respiratory Infections
• Hospital Acquired Infections
• Sexually Transmitted Infections

Gastrointestinal Infections

Oncology
Hepatitis
Prenatal/Neonatal Testing
Other Applications

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Hospitals
• Clinics & Diagnostic Centers
• Research and Academic Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America PoC molecular diagnostics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abacus Diagnostica Oy
Abbott Laboratories
Alere Inc.
Biocartis Group NV
Biomerieux SA
Bio-Rad Laboratories Inc
Danaher Corporation
DiaSorin S.p.A
DxNA LLC.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience Inc.
Mesa Biotech Inc.
QIAGEN N.V.
QuantuMDx Group Ltd.
Quidel Corporation
Spartan Biosciences Inc.
Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Kits & Assays
3.3 Analyzers & Instruments
3.4 Software & Services

4 SEGMENTATION OF NORTH AMERICA MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
  4.2.1 Real-Time PCR (rt-PCR)
  4.2.2 Digital PCR (d-PCR)
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.4 Genetic Sequencing-based Technology
4.5 Microarray-based Technology
4.6 Other Technologies

5 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Infectious Disease
  5.2.1 Respiratory Infections
  5.2.2 Hospital Acquired Infections
  5.2.3 Sexually Transmitted Infections
5.3 Gastrointestinal Infections
5.4 Oncology
5.5 Hepatitis
5.6 Prenatal/Neonatal Testing
5.7 Other Applications

6 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

6.1 Market Overview by End User
6.2 Hospitals
6.3 Clinics & Diagnostic Centers
6.4 Research and Academic Institutes
6.5 Other End Users

7 NORTH AMERICA MARKET 2019-2030 BY COUNTRY

7.1 Overview of North America Market
7.2 U.S.
7.3 Canada
7.4 Mexico

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Abacus Diagnostica Oy
Abbott Laboratories
Alere Inc.
Biocartis Group NV
Biomerieux SA
Bio-Rad Laboratories Inc
Danaher Corporation
DiaSorin S.p.A
DxNA LLC.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience Inc.
Mesa Biotech Inc.
QIAGEN N.V.
QuantuMDx Group Ltd.
Quidel Corporation
Spartan Biosciences Inc.
Thermo Fisher Scientific

9 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT

9.1 Risk Evaluation of North America Market
9.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of North America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in North America Point of Care (PoC) Molecular Diagnostics Market
Table 4. North America Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 5. North America Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 6. North America Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn
Table 7. North America Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 8. North America Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn
Table 9. North America Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn
Table 10. North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn
Table 11. U.S. Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 12. U.S. Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 13. U.S. Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 14. Canada Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 15. Canada Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 16. Canada Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 17. Mexico Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn
Table 18. Mexico Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn
Table 19. Mexico Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn
Table 20. Breakdown of North America Market by Key Vendor, 2019, %
Table 21. Abacus Diagnostica Oy: Company Snapshot
Table 22. Abacus Diagnostica Oy: Business Segmentation
Table 23. Abacus Diagnostica Oy: Product Portfolio
Table 24. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn
Table 25. Abacus Diagnostica Oy: Recent Developments
Table 26. Risk Evaluation for Investing in North America Market, 2019-2030
Table 27. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. North America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of North America Point of Care (PoC) Molecular Diagnostics Market
Figure 8. World Number of Deaths by Cause in 2017
Figure 9. World Number of Deaths from Cancers in 2017
Figure 10. Primary Restraints and Impact Factors of North America Point of Care (PoC) Molecular Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of North America Point of Care (PoC) Molecular Diagnostics Market
Figure 13. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue
Figure 14. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 15. North America Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn
Figure 16. North America Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn
Figure 17. North America Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn
Figure 18. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue
Figure 19. North America Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%)
Figure 20. North America Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn
Figure 21. North America Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn
Figure 22. North America Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn
Figure 23. North America Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn
Figure 24. North America Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn
Figure 25. North America Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn
Figure 26. North America Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn
Figure 27. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue
Figure 28. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 29. North America Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn
Figure 30. North America Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn
Figure 31. North America Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn
Figure 32. North America Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn
Figure 33. North America Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn
Figure 34. North America Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn
Figure 35. North America Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn
Figure 36. North America Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn
Figure 37. North America Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn
Figure 38. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue
Figure 39. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 40. North America Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn
Figure 41. North America Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn
Figure 42. North America Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn
Figure 43. North America Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn
Figure 44. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue
Figure 45. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 46. U.S. Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 47. Canada Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn
Figure 48. Point of Care (PoC) Molecular Diagnostics Market in Mexico, 2015-2030, $ mn
Figure 49. Growth Stage of North America Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period

COMPANIES MENTIONED

Abacus Diagnostica Oy
Abbott Laboratories
Alere Inc.
Biocartis Group NV
Biomerieux SA
Bio-Rad Laboratories Inc
Danaher Corporation
DiaSorin S.p.A
DxNA LLC.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience Inc.
Mesa Biotech Inc.
QIAGEN N.V.
QuantuMDx Group Ltd.
Quidel Corporation
Spartan Biosciences Inc.
Thermo Fisher Scientific